These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35078953)

  • 1. Increased Serum Level of CCL5 in Children with Attention‑Deficit/Hyperactivity Disorder: First Results about Serum Chemokines.
    Özaslan A; Güney E; Gülbahar Ö; Büyüktaskin D; Arslan B
    Clin Psychopharmacol Neurosci; 2022 Feb; 20(1):109-117. PubMed ID: 35078953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Heat Shock Protein 70 Level in Children with Attention Deficiency Hyperactivity Disorder.
    Özaslan A; Güney E; Gülbahar Ö; Büyüktaşkin Tunçtürk D; Arslan B; Güveli Bozkurt GM
    Noro Psikiyatr Ars; 2022; 59(1):63-67. PubMed ID: 35317506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
    Bilgiç A; Toker A; Işık Ü; Kılınç İ
    Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ciliary neurotrophic factor levels in children with attention deficit hyperactivity disorder.
    Buyuktaskin D; Guney E; Gulbahar O; Ozaslan A; Arslan B
    Int J Neurosci; 2024 Apr; 134(4):313-317. PubMed ID: 35815398
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased serum thioredoxin levels are not correlated with executive functions in children with attention deficit hyperactivity disorder.
    Guney E; Buyuktaskin D; Tas Torun Y; Arslan B; Gulbahar O; Ozaslan A; Isik Taner Y; Iseri E
    Neurosci Lett; 2019 Jul; 705():118-123. PubMed ID: 31028843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum zonulin and claudin-5 levels in children with attention-deficit/hyperactivity disorder.
    Aydoğan Avşar P; Işık Ü; Aktepe E; Kılıç F; Doğuç DK; Büyükbayram Hİ
    Int J Psychiatry Clin Pract; 2021 Mar; 25(1):49-55. PubMed ID: 32757874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron Deficiency Parameters in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Percinel I; Yazici KU; Ustundag B
    Child Psychiatry Hum Dev; 2016 Apr; 47(2):259-69. PubMed ID: 26092605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Interleukin-6 Level in Children With Attention-Deficit Hyperactivity Disorder (ADHD).
    Darwish AH; Elgohary TM; Nosair NA
    J Child Neurol; 2019 Feb; 34(2):61-67. PubMed ID: 30430896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory study to evaluate plasma vasopressin and apelin-13 levels in children with attention-deficit hyperactivity disorder.
    Bilgiç A; Toker A; Uysal S
    Psychiatry Clin Neurosci; 2016 Oct; 70(10):442-447. PubMed ID: 27283127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Galectin-3 Levels in Children with Attention-Deficit/Hyperactivity Disorder.
    Isık Ü; Kılıç F; Demirdas A; Aktepe E; Aydogan Avsar P
    Psychiatry Investig; 2020 Mar; 17(3):256-261. PubMed ID: 32151128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of the CC chemokines CCL2, CCL5, and CCL11 in food allergic children with different clinical manifestations.
    Radman M; Hassanshahi G; Vazirinejad R; Arababadi MK; Karimabad MN; Khorramdelazad H; Rafatpanah H; Iranmanesh F; Hakimizadeh E; Ahmadi Z
    Inflammation; 2013 Jun; 36(3):561-6. PubMed ID: 23180368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: a study on Iranian diabetic patients.
    Jamali Z; Nazari M; Khoramdelazad H; Hakimizadeh E; Mahmoodi M; Karimabad MN; Hassanshahi G; Rezaeian M; Balaei P; Darakhshan S; Poor NM
    Clin Lab; 2013; 59(9-10):993-1001. PubMed ID: 24273921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Levels of Interleukin-6 and Tumor Necrosis Factor Alpha in Children With Attention-Deficit Hyperactivity Disorder.
    Elsadek AE; Al-Shokary AH; Abdelghani WE; Kamal NM; Ibrahim AO; El-Shorbagy HH; Suliman HA; Barseem NF; Abdel Maksoud YH; Azab SM; Nour El Din DM
    J Pediatr Neurosci; 2020; 15(4):402-408. PubMed ID: 33936305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.
    Akay AP; Resmi H; Güney SA; Erkuran HÖ; Özyurt G; Sargin E; Topuzoglu A; Tufan AE
    Eur Child Adolesc Psychiatry; 2018 Jan; 27(1):127-135. PubMed ID: 28710695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of Serum Vascular Endothelial Growth Factor Levels in Attention Deficit Hyperactivity Disorder: A Case Control Study.
    Torun YT; Güney E; Aral A; Büyüktaşkin D; Tunca H; Taner YI; İşeri E
    Clin Psychopharmacol Neurosci; 2019 Nov; 17(4):517-522. PubMed ID: 31671489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine, Pyridoxine, Folate and Vitamin B12 Levels in Children with Attention Deficit Hyperactivity Disorder.
    Altun H; Şahin N; Belge Kurutaş E; Güngör O
    Psychiatr Danub; 2018 Sep; 30(3):310-316. PubMed ID: 30267523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of cortisol, dehydroepiandrosterone, and oxytocin in children with attention-deficit/hyperactivity disorder combined presentation with and without comorbid conduct disorder.
    Işık Ü; Bilgiç A; Toker A; Kılınç I
    Psychiatry Res; 2018 Mar; 261():212-219. PubMed ID: 29324397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered serum levels of vascular endothelial growth factor and glial-derived neurotrophic factor but not fibroblast growth factor-2 in treatment-naive children with attention deficit/hyperactivity disorder.
    Yurteri N; Şahin İE; Tufan AE
    Nord J Psychiatry; 2019; 73(4-5):302-307. PubMed ID: 31170860
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitamin D deficiency in school-age Iranian children with attention-deficit/hyperactivity disorder (ADHD) symptoms: A critical comparison with healthy controls.
    Fasihpour B; Moayeri H; Shariat M; Keihanidoust Z; Effatpanah M; Khedmat L
    Child Neuropsychol; 2020 May; 26(4):460-474. PubMed ID: 31514566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder.
    Baykal S; Albayrak Y; Durankuş F; Güzel S; Abbak Ö; Potas N; Beyazyüz M; Karabekiroğlu K; Donma MM
    Neurol Sci; 2019 Mar; 40(3):593-602. PubMed ID: 30617449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.